|
"wu hc"的相關文件
顯示項目 191-200 / 238 (共24頁)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每頁顯示[10|25|50]項目
| 中國醫藥大學 |
2003 |
Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease
|
Chen, WC; Chen, HY; Wu, HC; Wu, MC; Hsu, CD; Tsai, FJ |
| 中國醫藥大學 |
2003 |
Using Tc-99m DMSA renal cortex scan to detect renal damage in women with type 2 diabetes
|
Wu, HC; Chang, CH; Lai, MM; Lin, CC; Lee, CC; Kao, A |
| 中國醫藥大學 |
2003 |
Vascular endothelial growth factor gene-460 Ce/T polymorphism is a biomarker for prostate cancer
|
Lin, CC; Wu, HC; Tsai, FJ; Chen, HY; Chen, WC |
| 中國醫藥大學 |
2003 |
Vascular endothelial growth factor gene-460 Ce/T polymorphism is a biomarker for prostate cancer
|
Lin, CC; Wu, HC; Tsai, FJ; Chen, HY; Chen, WC |
| 中國醫藥大學 |
2003 |
Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy
|
Wu, HC; Lin, CC; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2003 |
Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy
|
Wu, HC; Lin, CC; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2003 |
Objective evidence of a high prevalence of renal damage in women with type 2 diabetes by technetium-99m DMSA renal cortex scan findings
|
Wu, HC; Huang, WS; Lin, CC; Lee, CC; Kao, A |
| 中國醫藥大學 |
2003 |
CYP17 gene promoter allelic variant is not associated with prostate cancer
|
Lin, CC; Wu, HC; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2003 |
CYP17 gene promoter allelic variant is not associated with prostate cancer
|
Lin, CC; Wu, HC; Chen, WC; Chen, HY; Tsai, FJ |
| 中國醫藥大學 |
2003 |
Association of E-cadherin gene 3 '-UTR C/T polymorphism with calcium oxalate stone disease
|
Tsai, FJ; Wu, HC; Che, HY; Lu, HF; Hsu, CD; Chen, WC |
顯示項目 191-200 / 238 (共24頁)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
每頁顯示[10|25|50]項目
|
